WO2002008417A1 - Process for producing recombinant protein - Google Patents

Process for producing recombinant protein Download PDF

Info

Publication number
WO2002008417A1
WO2002008417A1 PCT/JP2001/006392 JP0106392W WO0208417A1 WO 2002008417 A1 WO2002008417 A1 WO 2002008417A1 JP 0106392 W JP0106392 W JP 0106392W WO 0208417 A1 WO0208417 A1 WO 0208417A1
Authority
WO
WIPO (PCT)
Prior art keywords
recombinant protein
target protein
producing recombinant
dna
procaryotic
Prior art date
Application number
PCT/JP2001/006392
Other languages
French (fr)
Japanese (ja)
Inventor
Takashi Ito
Yoko Tanaka
Mitsuyo Kondo
Original Assignee
Takeda Chemical Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries, Ltd. filed Critical Takeda Chemical Industries, Ltd.
Priority to AU2002224555A priority Critical patent/AU2002224555A1/en
Priority to US10/343,095 priority patent/US20050209447A1/en
Priority to EP01984291A priority patent/EP1304376A4/en
Publication of WO2002008417A1 publication Critical patent/WO2002008417A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

It is intended to produce a target protein in procaryotic or eucaryotic cells. A DNA encoding the full-length amino acid sequence or a part of the same of a target protein is prepared and the target protein is produced by a gene recombination technique with the use of this DNA.
PCT/JP2001/006392 2000-07-25 2001-07-25 Process for producing recombinant protein WO2002008417A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2002224555A AU2002224555A1 (en) 2000-07-25 2001-07-25 Process for producing recombinant protein
US10/343,095 US20050209447A1 (en) 2000-07-25 2001-07-25 Process for producing recombinant protein
EP01984291A EP1304376A4 (en) 2000-07-25 2001-07-25 Process for producing recombinant protein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000-229064 2000-07-25
JP2000229064 2000-07-25

Publications (1)

Publication Number Publication Date
WO2002008417A1 true WO2002008417A1 (en) 2002-01-31

Family

ID=18722246

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/006392 WO2002008417A1 (en) 2000-07-25 2001-07-25 Process for producing recombinant protein

Country Status (4)

Country Link
US (1) US20050209447A1 (en)
EP (1) EP1304376A4 (en)
AU (1) AU2002224555A1 (en)
WO (1) WO2002008417A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1293567A1 (en) * 2000-06-21 2003-03-19 Takeda Chemical Industries, Ltd. Ligand to gpr8 and dna thereof
WO2003082907A1 (en) * 2002-03-29 2003-10-09 Euroscreen Sa Ligands for g protein coupled receptor gpr7 and uses thereof
EP1478394A2 (en) * 2002-02-27 2004-11-24 Immunex Corporation Polypeptide formulation
US7052674B2 (en) 2000-11-03 2006-05-30 The Regents Of The University Of California Prokineticin polypeptides, related compositions and methods
EP1946776A1 (en) * 2002-02-27 2008-07-23 Immunex Corporation Stabilized TNFR-Fc composition comprising arginine
US7858800B2 (en) 2004-06-30 2010-12-28 Banyu Pharmaceutical Co., Ltd. Biaryl derivatives
US9195095B2 (en) 2007-07-29 2015-11-24 Cree, Inc. LED lighting devices incorporating waveguides
US10307483B2 (en) 2016-10-21 2019-06-04 Amgen Inc. Pharmaceutical formulations and methods of making the same
US11607451B2 (en) 2005-06-14 2023-03-21 Amgen Inc. Self-buffering antibody formulations

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996009378A1 (en) * 1994-09-19 1996-03-28 The General Hospital Corporation Overexpression of mammalian and viral proteins
WO1997011086A1 (en) * 1995-09-22 1997-03-27 The General Hospital Corporation High level expression of proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4471197A (en) * 1996-10-09 1998-05-05 Srl Inc. Method for detecting nonsense mutations and frameshift mutations
JP4434479B2 (en) * 1997-07-09 2010-03-17 ザ・ユニバーシティ・オブ・クイーンズランド Nucleic acid sequences and methods for selectively expressing proteins in target cells and tissues
AUPP807899A0 (en) * 1999-01-08 1999-02-04 University Of Queensland, The Codon utilization
KR20010085850A (en) * 1998-09-29 2001-09-07 추후제출 Shuffling of codon altered genes
AUPP807799A0 (en) * 1999-01-08 1999-02-04 University Of Queensland, The Polynucleotide and method
SE0101519D0 (en) * 2001-04-27 2001-04-27 Astrazeneca Ab Nucleic ACID

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996009378A1 (en) * 1994-09-19 1996-03-28 The General Hospital Corporation Overexpression of mammalian and viral proteins
WO1997011086A1 (en) * 1995-09-22 1997-03-27 The General Hospital Corporation High level expression of proteins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1304376A4 *

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1293567A1 (en) * 2000-06-21 2003-03-19 Takeda Chemical Industries, Ltd. Ligand to gpr8 and dna thereof
US7671174B2 (en) 2000-06-21 2010-03-02 Takeda Pharmaceutical Company Limited Ligand to GPR8
EP1293567A4 (en) * 2000-06-21 2005-02-16 Takeda Pharmaceutical Ligand to gpr8 and dna thereof
US7193033B2 (en) 2000-06-21 2007-03-20 Takeda Pharmaceutical Company Limited Peptide having appetite stimulating activity
US7052674B2 (en) 2000-11-03 2006-05-30 The Regents Of The University Of California Prokineticin polypeptides, related compositions and methods
EP3210624A1 (en) * 2002-02-27 2017-08-30 Immunex Corporation Stabilized tnfr-fc composition comprising arginine
US8828947B2 (en) 2002-02-27 2014-09-09 Immunex Corporation Polypeptide formulation
EP1946776A1 (en) * 2002-02-27 2008-07-23 Immunex Corporation Stabilized TNFR-Fc composition comprising arginine
US7648702B2 (en) 2002-02-27 2010-01-19 Immunex Corporation Stable aqueous formulation of a soluble TNF receptor and arginine
EP1478394A2 (en) * 2002-02-27 2004-11-24 Immunex Corporation Polypeptide formulation
US11104714B2 (en) 2002-02-27 2021-08-31 Immunex Corporation Compositions comprising a P75 tumor necrosis factor receptor/Ig fusion protein
US8119604B2 (en) 2002-02-27 2012-02-21 Immunex Corporation Polypeptide formulation
EP1478394A4 (en) * 2002-02-27 2006-03-15 Immunex Corp Polypeptide formulation
US9518111B2 (en) 2002-02-27 2016-12-13 Immunex Corporation Compositions comprising a p75 tumor necrosis factor receptor/Ig fusion protein
WO2003082907A1 (en) * 2002-03-29 2003-10-09 Euroscreen Sa Ligands for g protein coupled receptor gpr7 and uses thereof
US7858800B2 (en) 2004-06-30 2010-12-28 Banyu Pharmaceutical Co., Ltd. Biaryl derivatives
US11607451B2 (en) 2005-06-14 2023-03-21 Amgen Inc. Self-buffering antibody formulations
US9195095B2 (en) 2007-07-29 2015-11-24 Cree, Inc. LED lighting devices incorporating waveguides
US10307483B2 (en) 2016-10-21 2019-06-04 Amgen Inc. Pharmaceutical formulations and methods of making the same
US11491223B2 (en) 2016-10-21 2022-11-08 Amgen Inc. Pharmaceutical formulations and methods of making the same

Also Published As

Publication number Publication date
EP1304376A4 (en) 2004-12-29
EP1304376A1 (en) 2003-04-23
US20050209447A1 (en) 2005-09-22
AU2002224555A1 (en) 2002-02-05

Similar Documents

Publication Publication Date Title
WO2000075350A3 (en) Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use
WO2001075087A8 (en) Subtilisin variants
WO2002046429A3 (en) Polypeptides having glucoamylase activity and nucleic acids encoding same
WO2002016583A3 (en) Constructs and their use in metabolic pathway engineering
WO2002006457A3 (en) Novel lipase genes
EP1137808A4 (en) Methods for making recombinant cells
DE602004028724D1 (en) METHOD FOR PRODUCING SEPARATED POLYPEPTIDES
EP1336652A4 (en) Cells to be used in producing virus vector, process for producing the same and process for producing virus vector with the use of the cells
WO2002008417A1 (en) Process for producing recombinant protein
CA2303061A1 (en) Lunasin peptides
WO2002030965A3 (en) Nucleic acids encoding stichodactylidae chromoproteins
WO2003014354A1 (en) Tyrosyl-trna synthase variants
WO2002008412A3 (en) Use of cyp52a2a promoter to increase gene expression in yeast
WO1993017031A3 (en) Nucleic acids encoding dystrophin-associated proteins
WO2000004162A3 (en) Genes encoding sulfate assimilation proteins
WO1995030001A3 (en) Novel p-selectin ligand protein
ATE458037T1 (en) LARGE-TECHNICALLY SUITABLE MICROORGANISM
WO1999053069A3 (en) Cell cycle regulatory proteins cdc2 and pitslre from plants
WO2003029457A1 (en) Process for producing amino acid
AU2002346803A1 (en) Genes encoding for carbon metabolism and energy-producing proteins
ATE288491T1 (en) POLYPEPTIDES WITH 5-AMINOLEVULIC ACID SYNTHASE ACTIVITY AND THEIR NUCLEIC ACIDS
WO2002048187A3 (en) Secretion signal peptides, their dna sequences, expression vectors for eukaryotic cells that can be produced with the same, and use thereof for biotechnological production of proteins
DE60037413D1 (en) RECOMBINANT ADHESINE PROTEINS FROM HAEMOPHILUS INFLUENZAE
WO2002046408A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2001040257A3 (en) Modified il-12 subunits and nucleic acids encoding them

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 10343095

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2001984291

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001984291

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

ENP Entry into the national phase

Ref document number: 2003132546

Country of ref document: RU

Kind code of ref document: A

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001984291

Country of ref document: EP